Literature DB >> 28498560

Deletion of α5 nicotine receptor subunits abolishes nicotinic aversive motivational effects in a manner that phenocopies dopamine receptor antagonism.

Taryn E Grieder1,2,3, Olivier George3, Mandy Yee1, Michael A Bergamini1, Michal Chwalek2, Geith Maal-Bared1, Hector Vargas-Perez2, Derek van der Kooy1,2.   

Abstract

Nicotine addiction is a worldwide epidemic that claims millions of lives each year. Genetic deletion of α5 nicotinic acetylcholine receptor (nAChR) subunits has been associated with increased nicotine intake, however, it remains unclear whether acute nicotine is less aversive or more rewarding, and whether mice lacking the α5 nAChR subunit can experience withdrawal from chronic nicotine. We used place conditioning and conditioned taste avoidance paradigms to examine the effect of α5 subunit-containing nAChR deletion (α5 -/-) on conditioned approach and avoidance behaviour in nondependent and nicotine-dependent and -withdrawn mice, and compared these motivational effects with those elicited after dopamine receptor antagonism. We show that nondependent α5 -/- mice find low, non-motivational doses of nicotine rewarding, and do not show an aversive conditioned response or taste avoidance to higher aversive doses of nicotine. Furthermore, nicotine-dependent α5 -/- mice do not show a conditioned aversive motivational response to withdrawal from chronic nicotine, although they continue to exhibit a somatic withdrawal syndrome. These effects phenocopy those observed after dopamine receptor antagonism, but are not additive, suggesting that α5 nAChR subunits act in the same pathway as dopamine and are critical for the experience of nicotine's aversive, but not rewarding motivational effects in both a nondependent and nicotine-dependent and -withdrawn motivational state. Genetic deletion of α5 nAChR subunits leads to a behavioural phenotype that exactly matches that observed after antagonizing dopamine receptors, thus we suggest that modulation of nicotinic receptors containing α5 subunits may modify dopaminergic signalling, suggesting novel therapeutic treatments for smoking cessation.
© 2017 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  conditioned place preference; genetic knockout mice; motivation; nicotine withdrawal; ventral tegmental area

Mesh:

Substances:

Year:  2017        PMID: 28498560      PMCID: PMC8162765          DOI: 10.1111/ejn.13605

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  34 in total

Review 1.  Addiction motivation reformulated: an affective processing model of negative reinforcement.

Authors:  Timothy B Baker; Megan E Piper; Danielle E McCarthy; Matthew R Majeskie; Michael C Fiore
Journal:  Psychol Rev       Date:  2004-01       Impact factor: 8.934

2.  Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking.

Authors:  W Berrettini; X Yuan; F Tozzi; K Song; C Francks; H Chilcoat; D Waterworth; P Muglia; V Mooser
Journal:  Mol Psychiatry       Date:  2008-01-29       Impact factor: 15.992

3.  Separate neural substrates mediate the motivating and discriminative properties of morphine.

Authors:  T V Jaeger; D van der Kooy
Journal:  Behav Neurosci       Date:  1996-02       Impact factor: 1.912

4.  Role of α5* nicotinic acetylcholine receptors in the effects of acute and chronic nicotine treatment on brain reward function in mice.

Authors:  Christie D Fowler; Luis Tuesta; Paul J Kenny
Journal:  Psychopharmacology (Berl)       Date:  2013-08-20       Impact factor: 4.530

5.  Efferent connections of the habenular nuclei in the rat.

Authors:  M Herkenham; W J Nauta
Journal:  J Comp Neurol       Date:  1979-09-01       Impact factor: 3.215

6.  Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice.

Authors:  Astrid K Stoker; Svetlana Semenova; Athina Markou
Journal:  Neuropharmacology       Date:  2008-04-08       Impact factor: 5.250

7.  Drug reinforcement studied by the use of place conditioning in rat.

Authors:  R F Mucha; D van der Kooy; M O'Shaughnessy; P Bucenieks
Journal:  Brain Res       Date:  1982-07-08       Impact factor: 3.252

8.  Chronic nicotine exposure switches the functional role of mesolimbic dopamine transmission in the processing of nicotine's rewarding and aversive effects.

Authors:  Huibing Tan; Stephanie F Bishop; Nicole M Lauzon; Ninglei Sun; Steven R Laviolette
Journal:  Neuropharmacology       Date:  2009-03       Impact factor: 5.250

9.  Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs.

Authors:  K J Jackson; B R Martin; J P Changeux; M I Damaj
Journal:  J Pharmacol Exp Ther       Date:  2008-01-09       Impact factor: 4.030

10.  Habenular α5 nicotinic receptor subunit signalling controls nicotine intake.

Authors:  Christie D Fowler; Qun Lu; Paul M Johnson; Michael J Marks; Paul J Kenny
Journal:  Nature       Date:  2011-01-30       Impact factor: 49.962

View more
  6 in total

1.  Chrna5-Expressing Neurons in the Interpeduncular Nucleus Mediate Aversion Primed by Prior Stimulation or Nicotine Exposure.

Authors:  Glenn Morton; Nailyam Nasirova; Daniel W Sparks; Matthew Brodsky; Sanghavy Sivakumaran; Evelyn K Lambe; Eric E Turner
Journal:  J Neurosci       Date:  2018-06-28       Impact factor: 6.167

2.  Mouse strain-specific acute respiratory effects of nicotine unrelated to nicotine metabolism.

Authors:  A J Bloom
Journal:  Toxicol Mech Methods       Date:  2019-06-21       Impact factor: 2.987

3.  β2* nAChRs on VTA dopamine and GABA neurons separately mediate nicotine aversion and reward.

Authors:  Taryn E Grieder; Morgane Besson; Geith Maal-Bared; Stéphanie Pons; Uwe Maskos; Derek van der Kooy
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-27       Impact factor: 11.205

4.  New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice.

Authors:  Deniz Bagdas; Yasmin Alkhlaif; Asti Jackson; F Ivy Carroll; Joseph W Ditre; M Imad Damaj
Journal:  Neuropharmacology       Date:  2018-05-21       Impact factor: 5.250

Review 5.  Neural circuits and nicotinic acetylcholine receptors mediate the cholinergic regulation of midbrain dopaminergic neurons and nicotine dependence.

Authors:  Cheng Xiao; Chun-Yi Zhou; Jin-Hong Jiang; Cui Yin
Journal:  Acta Pharmacol Sin       Date:  2019-09-25       Impact factor: 6.150

6.  Nicotine aversion is mediated by GABAergic interpeduncular nucleus inputs to laterodorsal tegmentum.

Authors:  Shannon L Wolfman; Daniel F Gill; Fili Bogdanic; Katie Long; Ream Al-Hasani; Jordan G McCall; Michael R Bruchas; Daniel S McGehee
Journal:  Nat Commun       Date:  2018-07-13       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.